Artes Medical Asks EPO, USPTO To Revoke Patents For Sanofi-Aventis Lipoatrophy Treatment
Artes Medical claims to have filed for a U.S. patent on a similar treatment in 1994. The opposition request to the EPO and the USPTO argues that Sculptra contains no innovation in comparison with that product.
The patent relates to the injectable microsphere implant technology used in its injectable skin fillers with the brand names Sculptra...
To view the full article, register now.